Get started
Author

Berbel L.M. Ykema

Observed names: B Ykema, B.L.M. Ykema, Berbel L M Ykema, Berbel L. M. Ykema, Berbel L. Ykema, Berbel Ykema, Ykema, B.L.M.
ORCID: 0000-0002-0314-7986
Observed ORCID: 0000-0002-0314-7986
OpenAlex ID: A5001550754
Cutaneous squamous cell carcinoma is associated with Lynch syndrome: widening the spectrum of Lynch syndrome‐associated tumours
2021 · B.L.M. Ykema, F. Adan, et al. · British Journal of Dermatology · 13
PDF
Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors
2020 · Berbel Ykema, Lisanne Rigter, et al. · Journal of Clinical Medicine · 6
PDF
Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2022 · Berbel L.M. Ykema, Andrea Gini, et al. · Cancer Epidemiology Biomarkers & Prevention · 4
PDF
Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study
2021 · Berbel L. M. Ykema, Tanya M. Bisseling, et al. · BMC Gastroenterology · 4
PDF
Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors
2022 · Berbel L. M. Ykema, Emilie C. H. Breekveldt, et al. · British Journal of Cancer · 3
PDF
Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin’s lymphoma survivors
2021 · Berbel L. M. Ykema, Lisanne S. Rigter, et al. · Digestive Endoscopy · 2
PDF
Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases
2020 · Berbel L. M. Ykema, Sanne J. M. Hoefnagel, et al. · PLoS ONE · 2
PDF
Platinum retention in plasma, urine, and normal colonic mucosa in cisplatin-treated testicular cancer survivors
2024 · Emilie C. H. Breekveldt, Berbel L. M. Ykema, et al. · PLoS ONE · 1
Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum‐based chemotherapy
2023 · Emilie C. H. Breekveldt, Berbel L. M. Ykema, et al. · International Journal of Cancer · 1
PDF
Compliance with mismatch repair testing in pT1 colorectal cancer diagnosed before the age of 70 years
2021 · Berbel L. M. Ykema, Iris D. Nagtegaal, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 1
Data from Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2023 · Berbel L.M. Ykema, Andrea Gini, et al.
Supplementary Figure from Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2023 · Berbel L.M. Ykema, Andrea Gini, et al.
Supplementary Data from Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2023 · Berbel L.M. Ykema, Andrea Gini, et al.
Supplementary Table from Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2023 · Berbel L.M. Ykema, Andrea Gini, et al.
Supplementary Table from Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2023 · Berbel L.M. Ykema, Andrea Gini, et al.
Supplementary Table from Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2023 · Berbel L.M. Ykema, Andrea Gini, et al.
Supplementary Figure from Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2023 · Berbel L.M. Ykema, Andrea Gini, et al.
Data from Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2023 · Berbel L.M. Ykema, Andrea Gini, et al.
Supplementary Table from Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2023 · Berbel L.M. Ykema, Andrea Gini, et al.
Supplementary Table from Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2023 · Berbel L.M. Ykema, Andrea Gini, et al.
Supplementary Table from Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2023 · Berbel L.M. Ykema, Andrea Gini, et al.
Supplementary Table from Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2023 · Berbel L.M. Ykema, Andrea Gini, et al.
Supplementary Figure from Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2023 · Berbel L.M. Ykema, Andrea Gini, et al.
Supplementary Figure from Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2023 · Berbel L.M. Ykema, Andrea Gini, et al.
Supplementary Table from Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
2023 · Berbel L.M. Ykema, Andrea Gini, et al.
Works count: 30
Citation count: 37
H-index: 4
I10-index: 1
Year
Topic
Type